Layer-specific Nos3 expression and genotypic distribution in bicuspid aortic valve aortopathy.
Layer-specific Nos3 expression and genotypic distribution in bicuspid aortic valve aortopathy.
复制标题
二叶式主动脉瓣主动脉病中层特异性 Nos3 表达和基因型分布。
DOI:
10.1093/ejcts/ezac237
复制
发表时间:
2022
期刊:
影响因子:
--
通讯作者:
Gleason,ThomasG
中科院分区:
文献类型:
--
作者:
Hill,JenniferC;Billaud,Marie;Richards,TaraD;Kotlarczyk,MaryP;Shiva,Sruti;Phillippi,JulieA;Gleason,ThomasG
OBJECTIVESWe hypothesized that expression and activity of nitric oxide synthase-3 enzyme (Nos3) in bicuspid aortic valve (BAV) aortopathy are related to tissue layer and Nos3 genotype.METHODSGene expression ofNos3andplatelet and endothelial cell adhesion molecule-1(Pecam1) and NOS activity were measured in intima-containing media and adventitial specimens of ascending aortic tissue. The presence of 2 Nos3 single-nucleotide polymorphisms (SNPs; −786T/C and 894G/T) was determined for non-aneurysmal (NA) and aneurysmal patients with BAV (n= 40, 89, respectively); patients with tricuspid aortic valve (TAV) and aneurysm (n= 151); and NA patients with TAV (n= 100).RESULTSElevatedNos3relative toPecam1and reducedPecam1relative to a housekeeping gene were observed within intima-containing aortic specimens from BAV patients when compared with TAV patients. LowerNos3in the adventitia of aneurysmal specimens was noted when compared with specimens of NA aorta, independent of valve morphology. NOS activity was similar among cohorts in media/intima and decreased in the diseased adventitia, relative to control patients. Aneurysmal BAV patients exhibited an under-representation of the wild-type genotype for −786 SNP. No differences in genotype distribution were noted for 894 SNP. Primary intimal endothelial cells from patients with at least 1 C allele at −786 SNP exhibited lowerNos3when compared with wild-type cells.CONCLUSIONSThese findings of differentialNos3in media/intima versus adventitia depending on valve morphology or aneurysm reveal new information regarding aneurysmal pathophysiology and support our ongoing assertion that there are distinct mechanisms giving rise to ascending aortopathy in BAV and TAV patients.